Physician profile
Jonathan Vacek
NPI 1962897538
$4,387.14
in general payments reported to CMS, 2019-2025
9 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 86% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $168 · 2023: $391 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,405 · Education: $1,000 · Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,404.59 |
| Education | $1,000.00 |
| Food and Beverage | $814.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,006.37 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Intuitive Surgical, INC. | $1,822.10 | 2025 | |
| Stryker Corporation | $167.60 | 2022 | |
| Medtronic, INC. | $94.28 | 2023 | Ligasure |
| Davol INC. | $91.60 | 2023 | Phasix Mesh |
| Karl Storz Endoscopy-America | $83.51 | 2023 | N.A. |
| Baxter Healthcare | $77.98 | 2023 | Floseal |
| Cerus Corporation | $23.63 | 2023 | Intercept Blood System For Platelets |
| Integra Lifesciences Corporation | $20.07 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Vacek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.